Q4 2021 Results
3.5
Participants
Company overview
Pharmaceuticals
Oncology
Financial review
Conclusion
Appendix
Novartis proposes 25th consecutive dividend increase to the
AGM: 3.10 CHF / share¹
3.0
CHF dividend
USD dividend
2.5
2.0
1.5
1.0
0.5
CAGR 7.6% in CHF and 9.6%4 in USD
2021 dividend yield 3.9%²
2021 dividend growth 3.3%³
CHF 3.00
USD 3.20
CHF 3.10
USD 3.39
0.0
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
1. Proposal to shareholders at the 2022 Annual General Meeting, taking place on March 4, 2022. 2. Based on closing share price of CHF 80.28 at end of business year 2021 (December 30, 2021). 3. In CHF. 4. Converted at historic
exchange rates at the dividend payment dates as per Bloomberg; for 2021, dividend per share translated into US dollars at the December 31, 2021, rate of USD 1.093 to the Swiss franc.
44 Investor Relations | Q4 2021 Results
✓ NOVARTIS | Reimagining MedicineView entire presentation